N. Wisch

发表

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.

B. Pasternack, D. Present, B. Korelitz, 1980, The New England journal of medicine.

Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms.

V. Najfeld, R. Hoffman, J. Goldberg, 2009, Experimental hematology.

Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasms

V. Najfeld, R. Hoffman, N. Wisch, 2009, Leukemia.

Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders.

R. Hoffman, J. Mascarenhas, N. Wisch, 2009, Blood.

Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders.

R. Hoffman, N. Wisch, M. Fiel, 2008, Blood cells, molecules & diseases.

Role of anticoagulants in preventing embolization from prosthetic heart valves.

R. Litwak, N. Wisch, J. Niemetz, 1967, JAMA.

Acute leukemia following cytotoxic chemotherapy.

R. Kaslow, N. Wisch, J. Glass, 1972, JAMA.

Long-term immunosuppressive therapy of ulcerative colitis

B. Korelitz, N. Wisch, J. Glass, 1973, The American Journal of Digestive Diseases.

Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine

B. Korelitz, N. Wisch, G. Gleim, 1999, American Journal of Gastroenterology.

Richter's syndrome. Findings on Ga-67 and bone marrow imaging.

N. Wisch, M. Lorberboym, C. K. Kim, 1996, Clinical nuclear medicine.

Hematologic complications of open heart surgery.

R. Litwak, N. Wisch, J. Glass, 1973, The American journal of cardiology.

Familial hypohaptoglobinemia. A genetically determined trait segragating from glucose-6-phosphate dehydrogenase deficiency.

A. Gottlieb, N. Wisch, J. Ross, 1963, Blood.

Hairy cell leukemia in association with thrombotic thrombocytopenic purpura and factor VIII antibodies.

J. Moake, N. Wisch, S. Lichtman, 1996, Leukemia & lymphoma.

Hematologic Complications of Inflammatory Bowel Disease and its Drugs Therapy

N. Wisch, 1982 .

Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis.

B. Korelitz, N. Wisch, 1972, The Surgical clinics of North America.

Chemotherapy of metastatic Merkel cell cancer.

L. Norton, M. Goldsmith, J. Crown, 1991, Cancer investigation.

HEMORRHAGE AND THROMBOSES ASSOCIATED WITH NEOPLASTIC DISORDERS.

N. Wisch, J. Niemetz, M. C. Rosenthal, 1963, Journal of chronic diseases.

Long term response of Crohn's disease to treatment with 6-mercaptopurine

D. Present, B. Korelitz, N. Wisch, 1978 .

Aplastic anemia resulting from the use of carbonic anhydrase inhibitors.

N. Wisch, J. Glass, I. Leopold, 1973, American journal of ophthalmology.

Long term therapy of ulcerative colitis with 6-mercaptopurine: A personal series

B. Korelitz, N. Wisch, 1972, The American Journal of Digestive Diseases.

Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression.

J. Tripodi, V. Najfeld, R. Hoffman, 2011, Cancer genetics.

Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation?

B. Korelitz, N. Wisch, J. Zlatanic, 1997, The American journal of gastroenterology.

Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women. A distinct syndrome.

N. Wisch, J. Feigert, J. Schulman, 1990, Annals of internal medicine.

Spurious fibrinogen levels secondary to pyroglobulinemia in Waldenström's macroglobulinemia

R. Lenzi, J. Rand, N. Wisch, 1995, American journal of hematology.

DUPLICATION q21 TO q26 OF CHROMOSOME 3 IN A PATIENT WITH ACUTE MYELOGENOUS LEUKAEMIA‐M1

V. Najfeld, N. Wisch, C. Theodossiou, 1992, British journal of haematology.